C ardiac diseases are delayed and less frequent in women than in men. 1, 2 The hormonal profile differs between women and men, and estrogens may exert their protective effects on the heart at multiple levels. Estrogen replacement in postmenopausal women reduces the risk of cardiovascular events, 3 and hypertension affects a more limited number of premenopausal women than men of a comparable age. 4 Similarly, heart failure of ischemic and nonischemic origin is predominantly a male disease. 1, 2 Although the pathogenesis of heart failure remains unclear, myocyte apoptosis may be 1 of the critical factors involved. 5, 6 Experimentally, myocyte apoptosis has been implicated in the transition from compensated to decompensated hypertensive hypertrophy 7 and in the acute restructuring of the wall and chamber dilation of the postinfarcted heart. 8 Prevention of cell death attenuates the impact of ischemic damage on ventricular anatomy and performance. 9, 10 A relevant question is whether the myocardium in women is less susceptible to death signals and possesses an inherent ability to counteract the activation of the endogenous cell death pathway. Cell death occurs by apoptosis, necrosis, and the combination of both. 11, 12 The possibility that myocyte death is reduced in women is consistent with observations in the aging heart. The male heart loses 64ϫ10 6 myocytes per year during adulthood and senescence; the female heart does not. 13 However, the cause of myocyte loss with aging remains to be identified because methods for the detection of apoptosis and necrosis in humans have not previously been available. The current study tested the hypothesis that apoptotic, necrotic, and apoptotic-necrotic myocyte death differ in the failing hearts of women and men.
Hearts from female and male patients who were undergoing cardiac transplantation were examined, and each form of cell death was measured. In this population, impairment in ventricular function is essentially identical. This allowed us to document whether cell death is reduced in women, despite the similarity of the overload. Probes capable of identifying DNA damage, 14, 15 as reflected by myocyte apoptosis and/or necrosis, were used for the first time in the human heart. These evaluations were complemented with the electrophoretic analysis of low-molecularweight DNA obtained from isolated myocytes. In a subset of patients, the fraction of myocytes showing morphological changes consistent with apoptosis or necrosis was assessed by electron microscopy.
Materials and Methods

Patients
Anatomical and functional properties of the heart were measured by 2-dimensional echocardiography in 26 patients, 9 women and 17 men, before transplantation. Pressure measurements were determined by cardiac catheterization. Three women had ischemic cardiomyopathy, and 6 had dilated cardiomyopathy. Eight men had ischemic cardiomyopathy, and 9 had dilated cardiomyopathy. Samples of the left ventricle were fixed in formalin and embedded in paraffin. Control myocardium was obtained from 5 women and 5 men at autopsy 13 and surgically from the papillary muscles of 4 women and 4 men who had mitral stenosis.
Myocyte Apoptosis and Necrosis
A Taq probe was prepared as previously described. 14, 16 Digoxigeninlabeled probes were ligated to DNA using the T4 ligase. Sections were incubated with anti-digoxigenin and exposed to FITC-labeled goat anti-mouse IgG. For confocal microscopy, sections were stained with ␣-sarcomeric actin and propidium iodide (PI). 6, 16, 17 The Pfu probe was prepared in a similar manner, except that Pfu polymerase was used instead of Taq. 14 For terminal deoxynucleotidyl transferase (TdT), sections were treated with a well-established procedure. 6, 16, 17 For double-labeling, sections were processed first with Pfu and then with TdT. To distinguish TdT from Pfu staining of nuclei, TdT was performed with rhodamine-labeled extravidin.
Single-base 3Ј overhangs are identified by a polymerase chain reaction-generated Taq polymerase probe that possesses complementary structures ( Figure 1A ). Using the T4 ligase, this probe interacts only with damaged DNA exhibiting single-base 3Ј overhangs. The TdT assay recognizes staggered ends in the DNA with Ն1 and Յ4 bases of 3Ј overhangs. TdT links several molecules of biotinylated deoxyuridine 5-triphosphate to 3Ј overhangs, and this tail is visualized by extravidin labeled with FITC ( Figure 1B) . Thus, apoptosis mediated by DNase I (Taq) 14, 18 or by both DNase I and DNase II (TdT) 14, 18 can be identified. During necrosis, the release of lysosomal proteases degrades histones, resulting in the loss of DNA protection and exposure to endonucleases and exonucleases. 19 Endonucleases produce double-strand DNA cleavage with recessed 3Ј or 3Ј overhangs. 14, 18 Exonucleases remove terminal nucleotides, leading to a form of damage with blunt DNA ends. 14 These are recognized by the Pfu probe, which contains blunt ends ( Figure 1C ). To confirm that Pfu-positive nuclei reflected myocyte necrosis with disruption of the sarcolemma, sections were stained by Pfu and vinculin. Vinculin is more prominent in costameres, but it clearly defines the continuity of the sarcolemmal surface. 20 
Myocyte DNA Gel Electrophoresis
Left ventricular myocytes were isolated from 3 control and 7 failing hearts using the methodology for enzymatic dissociation of myocytes in the dog heart. 17 The presence of low-molecular-weight DNA fragments was then determined. 6, 15, 16 
Electron Microscopy of Myocyte Apoptosis and Necrosis
Samples from 6 failing hearts were fixed, processed for electron microscopy, and analyzed. 21 
Statistical Analysis
Results are presented as meanϮSD. Significance at PϽ0.05, between 2 or multiple groups, was determined by Student's t test and the Bonferroni method.
An expanded Materials and Methods section is available online at http://www.circresaha.org.
Results
Heart Samples
Hearts from 26 patients, 9 women and 17 men, who underwent cardiac transplantation, were studied (Table) . All patients were treated with inotropic drugs, diuretics, and angiotensin-converting-enzyme inhibitors. The age of the 9 women varied from 41 to 61 years. Ten autopsy hearts were used as controls. Samples were collected 1 to 7 hours after death in 5 women (aged 54Ϯ11 years) and 5 men (aged 46Ϯ16 years). These specimens were used for the detection of apoptosis by TdT and Taq probes. Only 1 female and 1 male heart could be used for baseline measurements of necrosis by Pfu because they were available within 2 hours after death. Additional sampling consisted of 8 papillary muscles obtained from patients of comparable age (4 women aged 58Ϯ2 years and 4 men aged 57Ϯ6 years), who had valve replacement for mitral stenosis. These were not healthy individuals. Although we recognize this limitation, a more appropriate control tissue was not found.
Myocyte Apoptosis
Internucleosomal DNA cleavage was measured separately in female and male hearts by TdT and Taq polymerase assays. Taq polymerase yields products with single-base 3Ј over- hangs. 14, 16 TdT reaction with a fluorescent probe identifies staggered ends of the cleaved DNA, 6 but it does not distinguish between single-base or longer 3Ј overhangs. 22 Figure 2 illustrates that control myocardium, exposed to DNase I, showed positive TdT and Taq labeling but negative Pfu staining, indicating that apoptosis was not recognized by Pfu. Chromatin margination and fragmentation are apparent by Taq in a myocyte of a woman with dilated cardiomyopathy (Figure 3 , A through C). Myocyte apoptosis in a man with ischemic cardiomyopathy is demonstrated by TdT in Figure 3 , D through F. Analysis of apoptosis in 7 women included the examination of 428 373 and 536 792 myocyte nuclei by Taq and TdT, respectively. Corresponding values in 12 men were 704 216 and 714 212. In the 10 control hearts obtained at autopsy, 902 754 nuclei were counted after Taq and 469 865 after TdT. Levels of apoptosis with these methods were not different in hearts with ischemic or dilated cardiomyopathy. Thus, results were combined in each sex group. Control values with Taq and TdT were essentially identical in women and men; data were pooled in a single group of 10 hearts. With failure, myocyte apoptosis, measured by Taq and TdT, was 2.2-fold (PϽ0.003) and 2.5-fold (PϽ0.001) higher in men than in women, respectively ( Figure 4 ). With respect to controls, failure resulted in an 85-fold (PϽ0.0001) and 35-fold (PϽ0.02) increase in apoptosis in men and women, respectively.
Myocyte Necrosis
During necrosis, the release of endonucleases and exonucleases from lysosomes produces DNA fragments with blunt ends, 19 which are recognized by Pfu. 14 The inability of Pfu to identify myocyte apoptosis was documented in Figures 2E and 2F. Moreover, omission of the T4 ligase resulted in negative staining. Additional controls for the specificity of detection of necrotic cells by Pfu were established previously by the simultaneous analysis of myosin-antibody staining of necrotic myocytes in vivo 15 and in vitro. 23 Myocardial infarction is characterized by both necrotic and apoptotic myocyte death, 13, 24 as seen in Figures 5A through 5C, which illustrate Pfu-positive nuclei in the infarcted region of a male heart 4 days after the acute event. Cells were also TdT positive. A Pfu-labeled necrotic myocyte is shown in Figures 5D through 5F in a woman affected by dilated cardiomyopathy. Doublelabeling with Pfu and TdT was done to detect necrotic-apoptotic myocytes in pathological hearts. Two cells were positive for both stainings: 1 in a man ( Figure 6 ) and 1 in a woman with ischemic cardiomyopathy.
Quantitatively, myocyte necrosis involved counting 439 881 and 465 844 myocyte nuclei in female and male pathological hearts, respectively. In controls, 231 015 nuclei were examined ( Figure 7) . Results from hearts with ischemic and dilated cardiomyopathy were comparable, and they were included in a single group in each sex. Values in female and male control myocardium were also similar and combined. With heart failure, myocyte necrosis was nearly 2-fold (PϽ0.001) higher in men than in women. Moreover, with respect to baseline, this form of cell death increased 13-fold (PϽ0.002) and 27-fold (PϽ0.0001) in female and male diseased hearts, respectively. Examination of a large number of myocyte profiles by confocal microscopy showed that the majority of cells had continuity of the plasma membrane ( Figure 8A ). When sarcolemmal disruption was detected by vinculin staining, nuclei were Pfu-positive (Figure 8 , B through D). In 200 myocytes, 100 each from the male and female failing hearts, Pfu labeling of nuclei was associated with membrane damage in all cases. This indicated that double-strand cleavage of DNA with blunt ends occurred exclusively in combination with membrane injury. Figure 9 illustrates, by confocal microscopy, enzymatically dissociated myocytes that were used to detect DNA diffusion Onset of disease to heart failure, mo 77Ϯ83 54Ϯ56
Myocyte DNA Agarose Gel Electrophoresis
Time from heart failure to transplantation, mo 24Ϯ24 14Ϯ11
Results are presented as meanϮSD.
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(ie, necrosis), DNA laddering (ie, apoptosis), and the simultaneous presence of both. In myocytes from a female heart with ischemic cardiomyopathy, laddering was barely detectable, and it was restricted at 200 bp ( Figure 10A, lane 2) . In a similar male heart, DNA diffusion was apparent, and laddering was visible at 200, 400, and 600 bp ( Figure 10A , lane 3). Moderate DNA diffusion was seen in a sample from a female heart with dilated cardiomyopathy ( Figure 10A , lane 4); DNA laddering was not noted. Additional cases of DNA damage in myocytes from failing hearts are shown in Figure  10B . DNA diffusion and a laddering pattern with different intensities at 200, 400, and 600 bp were observed in male hearts with ischemic ( Figure 10B , lanes 3 and 5) and dilated ( Figure 10B, lanes 6 and 7) myopathies. The preparation of female myocytes shown previously ( Figure 10A , lane 2) was included for comparison with male myocytes. In all cases of heart failure, male myocytes showed greater levels of DNA diffusion and laddering than female myocytes.
Electron Microscopy of Myocyte Apoptosis and Necrosis
Electron microscopy of 5 tissue blocks in each of 4 male hearts with cardiac failure included the analysis of 1752, 1478, 1533, and 1697 myocyte profiles. In the 2 female failing hearts, 1882 and 1684 myocyte profiles were examined. The fraction of cells with morphological changes characteristic of apoptosis (ie, chromatin margination, condensation, clumping and discontinuity of nuclear membranes; Figure 11 , A and B) was determined; 3, 6, 2, and 5 myocytes with these properties were found in the 4 male hearts, and 2 and 1 in the 2 female hearts. Percentages of apoptosis in men were 0.17%, 0.41%, 0.13%, and 0.29%, and percentages of apoptosis in women were 0.11% and 0.06%. The same sampling was used to compute necrotic cells. Myocytes with membrane discontinuity and diffuse swelling ( Figure 11C ), severe disruption of mitochondrial cristae and swelling, and almost complete disorganization of cell structure were observed. These morphological alterations with unspecific nuclear damage reflected cell necrosis. In men, 18, 20, 9, and 16 myocytes had some of these aspects ( Figure 11C ). In the 4 cases, myocyte necrosis was 1.03%, 1.35%, 0.59%, and 0.94%. Detection of myocyte apoptosis in female heart with dilated cardiomyopathy (A through C) and in male heart with ischemic cardiomyopathy (D through F). A and D illustrate nuclei stained by PI (red); B and E depict, respectively, Taq and TdT labeling of apoptotic nuclei (green); C and F show ␣-sarcomeric actin staining of myocyte cytoplasm (red) and combination of PI with Taq (C) or TdT (F) labeling of nuclei (yellow). Arrowheads indicate apoptotic nuclei. A through F, ϫ800.
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In women, 13 and 6 cells showed necrotic changes, corresponding to 0.69% and 0.36%. Occasionally, necrosis involved groups of 2 to 4 cells.
Discussion
Sex and Myocyte Death
Results in the current study indicate that myocyte death occurred in the failing heart, but its magnitude differed significantly in women and men. Myocyte necrosis and apoptosis were markedly lower in women than in men. The reduced incidence of cell death in women was apparent, although the disease and cardiac failure were present for a longer time. Higher myocyte death in men was associated with a shorter duration of the myopathy and an earlier onset of heart failure. In women, the average times from the beginning of the morbid state to impairment in function and from diagnosis to transplantation were 77 and 24 months, respectively. In men, these intervals were 54 and 14 months, respectively. The entire length of the disease at transplantation was 101 and 68 months in women and men, respectively. These observations suggest that the chronic loss of myocytes plays a critical role in the initiation of ventricular dysfunction and its progression to severe cardiac decompensation. Recent clinical results are consistent with this possibility. 25 The extent of cell death correlates with alterations in ventricular hemodynamics with age, 23 systemic hypertension, 7 and ischemic injury 24 in rats and dogs. Interference with cell death in the surviving myocardium after infarction or coronary constriction decreases ventricular loading, chamber dilation, and hypertrophy in mice. 9, 15 Similar findings have been obtained when cell death was inhibited in hypertensive rats 7 and in failing dogs. 10 The mechanism responsible for reduction in myocyte death in women with cardiac failure is unknown. The hormonal profile differs in women and men, and estrogens phosphorylate insulin-like growth factor-1 (IGF-1) receptors, improving cell survival. 26 Although it was not possible to determine whether women in this study were on estrogen-supplemented therapy, changes in circulating levels of IGF-1 and IGF binding proteins (IGFBP) exerted a less significant role than their corresponding tissue concentrations. 27 In this regard, a complete dissociation has been found between the adaptation of the systemic and local IGF-1 and IGFBP in pathological states 28 ; IGF-1 was not reduced in the myocardium with uremia, despite extreme levels of IGFBPs.
Estrogen may enhance the phosphorylation of IGF-1R in myocytes, because these cells can produce the sex hormone throughout life. 29 Aging is characterized by a reduction in the circulating precursor pool of estrogen, androstenedione, and testosterone in women more than men. 30 However, the ability to generate estrogen is higher in female myocytes, even in the presence of lower circulating amounts of C 19 precursors. 31 As a consequence, estrogen receptors increase. 32 Additionally, the stimulation of the IGF-1/IGF-1 receptor system enhances the expression of antiapoptotic gene products, such as Bcl-2 and Bcl-x L , 33 and decreases the induction of proapoptotic proteins, such as Bax. 34 Changes in these regulators of cell death may dictate the cell reaction to a death stimulus. IGF-1 activates the phosphatidylinositide-3Ј-OH kinase/Akt pathway, which suppresses cell death. 35 Estrogen and IGF-1 stimulate NO, 36, 37 which promotes vasodilation 37 and antithrombotic and antiinflammatory responses. 38 These factors increase tissue oxygenation and may counteract necrotic death signals in women.
Necrosis, Apoptosis, and Heart Failure
Myocyte apoptosis occurs in end-stage cardiac failure. 5, 6 However, apoptosis involves, at most, 1% of myocytes 6 ; this value may challenge the impact of this phenomenon on the final outcome of the pathological state. Low levels of apoptosis were confirmed in the present study in the decompensated heart; levels were 0.18% in men and 0.08% in women. Importantly, myocyte necrosis comprised 1.2% of myocytes in men and 0.5% in women, which exceeded apoptosis in both sexes. Although the number of necrotic myocytes was several-fold greater than apoptotic myocytes in the male and female myocardium, the time required for the completion of each form of cell death is unknown. Labeling of DNA strand-breaks in myocyte nuclei by TdT or Taq corresponds to the early phases of apoptosis and does not provide information on the sequence of events taking place in the cell after nuclear fragmentation. Similarly, the recognition of myocyte necrosis by Pfu leaves unanswered the question concerning the duration of the necrotic process. In vitro studies in various model systems have shown that apoptosis may be completed in a period ranging from 30 minutes to 2 hours. 23 However, no indication exists of the time required for myocyte apoptosis. An identical limitation applies to myocyte necrosis; this form of cell death has been claimed to reach its final stage in 1 to 2 days in infarcted rats. 12 This period is necessary for the cell to be engulfed by surrounding macrophages. Apoptosis may be much faster than necrosis, suggesting that the higher value of myocyte necrosis in the failing heart may not reflect a significant difference in the number of cells dying by these 2 distinct mechanisms.
If the assumption is made that at any time, nearly 1.5% of myocytes are experiencing cell death, the heart should rapidly disappear. This contention does not consider 2 Figure 4 . Effects of heart failure (HF) on myocyte apoptosis measured by Taq (A) and TdT (B) in female (F) and male (M) hearts. Results are meanϮSD. C indicates control hearts; *, difference from control value; and **, difference between men and women with heart failure.
critical points: (1) myocyte proliferation does occur in the failing heart, 39 and (2) these hearts are in the terminal phase of decompensation. The current findings do not characterize the mechanisms by which ventricular dysfunction deteriorates chronically; they show the end-stage, premortal condition of the disease. Ongoing cell death was documented by 6 different techniques: apoptosis by Taq and TdT labeling; necrosis by Pfu labeling and vinculin distribution; apoptosis and necrosis by electron microscopy; and apoptosis and necrosis by DNA laddering and diffusion of low-molecular-weight DNA in isolated myocyte preparations.
The cause of myocyte death with cardiac failure remains to be identified. Additionally, it is not apparent why apoptosis and necrosis occur simultaneously in ischemic and dilated cardiomyopathy. Alterations in coronary blood Male infarcted heart at 4 days (A through C) and female heart with dilated cardiomyopathy (D through F). A and D, Nuclei stained by PI (red). B and E, Pfu-labeling of necrotic nuclei (green). C and F, ␣-sarcomeric actin staining of myocyte cytoplasm (red) and combination of PI and Pfu-labeling of nuclei (yellow). A through C, ϫ200; D through F, ϫ800.
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Circulation Research October 29, 1999 flow are severe in the decompensated heart, 40 and these defects in coronary perfusion and tissue oxygenation may trigger necrotic and apoptotic myocyte death. Transient ischemia activates myocyte apoptosis, but sustained reductions in coronary blood flow result in myocyte necrosis, which exceeds apoptosis. 15 Although the primary event differs in ischemic and dilated cardiomyopathy, foci of replacement fibrosis and collagen accumulation are present in the noninfarcted myocardium and throughout the ventricular wall of the dilated myopathy. 6, 23 These pathological processes parallel the abnormalities in blood supply to the myocardium. 40 In the current study, myocyte apoptosis was the result of double-strand cleavage of the DNA with single base 3Ј overhangs, which occur only through the activation of DNase I. 14, 16 Systemic and local factors may increase cytosolic Ca 2ϩ and trigger apoptosis. Importantly, end-diastolic pressure is elevated in heart failure, and sarcomere stretching upregulates the myocyte renin-angiotensin system, leading to the formation and release of angiotensin II. 16 Activation of the angiotensin II AT 1 receptor subtype effector pathway may increase intracellular Ca 2ϩ , stimulate DNase I, and ultimately induce myocyte apoptosis. 23 This is consistent with the beneficial effects of inhibition of the systemic and local renin-angiotensin system on heart failure. 41 
Detection of Apoptotic and Necrotic Cell Death
Recently developed molecular probes have allowed the identification of double-strand cleavage of nuclear DNA with staggered or blunt ends. These forms of DNA damage correspond to apoptosis and necrosis, respectively. Additionally, vinculin localization in the plasma membrane permits the unequivocal recognition of membrane rupture, a feature of cell necrosis. The combination of these stainings with confocal microscopy provides the simultaneous visualization of discontinuity of the plasma membrane, morphological changes in chromatin and nuclear structure, and the detection of typical forms of DNA injury. The electrophoretic pattern of DNA complements, on a biochemical level, these histochemical methods. Although these approaches for the measurement of cell death have been emphasized, 42 electron microscopy has been proposed as an alternative method of investigation. The major problem is the difference in sam- Figure 6 . Myocyte apoptosis (TdT) and necrosis (Pfu) in male heart with ischemic cardiomyopathy. A through C indicate, numerically, 3 nuclei. A, only nuclei 1 and 3 are labeled by TdT (red). Note fragmentation in nucleus 1. Nucleus 2 is not stained in A. B, nuclei 2 and 3 are labeled by Pfu (green), whereas nucleus 1 is not stained. Thus, nucleus 1 is affected by apoptosis only and nucleus 2 by necrosis only. Nucleus 3 is undergoing apoptosis (red) and necrosis (green). C represents combination of A and B and shows ␣-sarcomeric actin staining of myocyte cytoplasm (red). A through C, ϫ1200. pling between electron microscopy and confocal microscopy. In electron microscopy, an average section is 0.2 mm 2 in area and 70 nm in thickness, whereas in confocal microscopy, an average section is 150 mm 2 in area and 5 m in thickness. The latter can be examined by optical sectioning. This is particularly relevant when the magnitude of cell death is, at most, 1%. On this basis, electron microscopy requires an extravagant number of sections and pictures to maintain a sampling error within 10%. 21 Because of this limitation, the values obtained by electron microscopy in this study were not shown statistically (meanϮSD).
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This work was supported by National Institutes of Health grants HL-38132, HL-39902, HL-43023, and AG-15756. Figure 8 . A, Localization of vinculin in plasma membrane of myocytes in control heart. Myocytes are longitudinally oriented. B, Detection of myocyte necrosis by Pfu-labeling of nucleus (yellow, arrow) and disruption of plasma membrane by segmental absence of vinculin (yellow, arrowheads). Myocyte cytoplasm shows ␣-sarcomeric actin (red). Red fluorescence of nuclei corresponds to PI. C illustrates distribution of vinculin and nucleus labeled by Pfu (green). D depicts Pfu-labeling of nucleus (yellow); nucleus is surrounded by cytoplasm of myocyte lacking plasma membrane (vinculin-negative) and interstitial inflammatory cell nuclei border necrotic myocyte. Nuclei are illustrated separately in E by attenuated red fluorescence of PI. Arrows in C through E indicate necrotic myocyte. A, ϫ600; B, ϫ1000; and C through E, ϫ1200. 11 . A, Female heart with dilated cardiomyopathy showing myocyte nucleus with clumping (arrow) and peripheral distribution of chromatin. B, Male heart with ischemic cardiomyopathy and myocyte nucleus showing meandering deep invaginations with chromatin condensation (arrow) and initial nuclear fragmentation (arrowhead). Nuclear membrane discontinuity (double arrows) is apparent. Mitochondrial swelling and partial loss of cristae reflect artifacts caused by immersion fixation. C, Male heart with dilated cardiomyopathy showing disruption of plasma membrane and severe cytoplasmic swelling of necrotic myocyte. A and B, ϫ25 000; C, ϫ5000.
